Cryo Cell International Inc

CCEL

Exchange: NYSE
Industry: Services-Misc Health & Allied Services, NEC
SEC CIK: 0000862692

SEC filings (opens in a new tab)

No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Cryo Cell International Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of CCEL: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Q2 2022	Change
Holders	12	13	+1
Shares	746.8K	755.0K	+8.16K (+1.1%)
Value	$5.70M	$4.45M	−$1.24M (−21.8%)

New holders (2)

Institutions that held Cryo Cell International Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CCEL in Q2 2022
Institution	Shares	Value	% of portfolio
BlackRock Inc.	12,123	$71.0K	0.00%
Royal Bank of Canada	2,200	$13.0K	0.00%

Sold out (1)

Institutions that held Cryo Cell International Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CCEL in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Seizert Capital Partners, LLC	43,483	$332.0K